Research Article
Olanzapine 5 mg for Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma Receiving Cisplatin-Based Concurrent Chemoradiotherapy
Figure 1
The incidence of complete response (a) and no nausea (b) in olanzapine 5 mg and 10 mg groups from day 1 (the initiation of cisplatin) to day 5.
(a) |
(b) |